• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There are few data regarding how exposure over time may affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking adhd medication Pregnancy (glamorouslengths.Com) medication need to weigh the benefits of taking it against the potential risks for the foetus. Physicians don't have the information needed to provide clear recommendations, but they can provide information regarding risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face an increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a large population-based study of case control to compare the incidence of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was accurate and to eliminate any bias.

However, the researchers' study was not without its flaws. The researchers were not able to, in the first place to differentiate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the small differences observed between the groups exposed were due to the use of medications, or if they were affected by comorbidities. Additionally, the researchers did not examine the long-term outcomes of offspring.

The study found that babies whose mothers had taken ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages may be offset by the greater benefits to both mother and baby of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, when they are able, assist them in developing strategies to improve their coping abilities which can reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of solid and reliable evidence in either case, which means that doctors have to weigh their experience, the experiences of other doctors, and what research suggests on the subject as well as their own judgments for each patient.

In particular, the issue of possible risks to the baby can be a challenge. The research on this issue is based on observation rather than controlled studies and many of the findings are contradictory. The majority of studies focus on live-births, which adhd medication is best for me quiz could underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion: While some studies have found an association between ADHD medications and the risk of certain birth defects, others have found no connection and the majority of studies demonstrate a neutral or slight negative effect. In each case it is imperative to conduct a thorough study of the benefits and risks should be conducted.

It can be difficult, if not impossible, for women with ADHD to stop taking their medication. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can doctors prescribe adhd medication lead to increased depression, feelings types of adhd medication uk isolation, and family conflict for those suffering from the disorder. A loss of medication may also affect the ability to safely drive and complete work-related tasks, which are crucial aspects of everyday life for those with ADHD.

She suggests that women who are unsure about whether to continue or stop taking medication because of their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment plan. Educating them can also help the woman feel supported in her struggle with her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug could be passed on to her infant.

Risk of Birth Defects

As the use and use of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so does concern about the possible effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Using two massive data sets researchers were able to analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The authors of the study did not discover any link between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are in agreement with previous studies that have shown a small, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of pregnancy. This risk increased during the latter half of pregnancy, when a lot of women decided to stop taking their medication.

Women who took ADHD medication in the first trimester of their pregnancies were also more likely to have caesarean section, low Apgar score after delivery and a baby who required breathing assistance during birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to these findings.

The researchers hope their study will help inform the clinical decisions of physicians who treat pregnant women. They suggest that although a discussion of the risks and benefits is crucial, the decision to stop or maintain medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, while stopping the medication is a possibility to think about, it isn't recommended because of the high incidence of depression and other mental disorders among women who are pregnant or recently gave birth. Further, the research suggests that women who choose to stop their medications are more likely to have difficulties getting used to life without them after the birth of their baby.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from adhd medication names for adults who have to manage their symptoms while attending physician appointments and making preparations for the arrival of a child and adjusting to new household routines may face a lot of challenges. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medications are absorbed by breast milk in low amounts, therefore the risk for nursing infant is very low. The amount of exposure to medications can vary depending upon the dosage, frequency of administration and time of day. Additionally, different medications enter the infant's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn isn't fully understood.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult decision for the mother, who must weigh the advantages of her medication against the risk to the foetus. Until more information is available, GPs should ask all pregnant patients about their history of ADHD and whether they are planning or taking to take medication during the perinatal period.

Many studies have shown that women can continue taking their ADHD medication safely while breastfeeding and during pregnancy. In the end, more and more patients choose to do so, and after consulting with their doctor, they have found that the benefits of continuing their current medication far outweigh any risks.

Women with ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also learn about treatment options and reinforce the coping mechanisms. This should include a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Counselling for pregnancy should include the discussion of a plan for management for both the mother as well as the child, monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.